Related references
Note: Only part of the references are listed.Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Suvadeep Mal et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation
Chaoquan Tian et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and evaluation of phthalide alkyl tertiary amine derivatives as promising acetylcholinesterase inhibitors with high potency and selectivity against Alzheimer's disease
Li Luo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer's disease
Ziyi Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents
Yinling Yun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease
Avanish Tripathi et al.
BIOORGANIC CHEMISTRY (2020)
Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Ana Xu et al.
BIOORGANIC CHEMISTRY (2020)
Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives
Harapriya Chakravarty et al.
DRUG DEVELOPMENT RESEARCH (2020)
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease
Julien Lalut et al.
SCIENTIFIC REPORTS (2020)
Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Devendra Kumar et al.
CURRENT DRUG TARGETS (2020)
The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease
Hui-Ju Tseng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances
Wenzhang Wang et al.
MOLECULAR NEURODEGENERATION (2020)
Design, Synthesis and Evaluation ofO-Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors
Vijay Kumar et al.
CHEMISTRYSELECT (2020)
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
Xiao-Bing Wang et al.
RSC MEDICINAL CHEMISTRY (2020)
Discovery of 4′-OH-flurbiprofen Mannich base derivatives as potential Alzheimer's disease treatment with multiple inhibitory activities
Hongyan Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents
Mohammad Mahdavi et al.
CHEMISTRY & BIODIVERSITY (2019)
Predictions of Alzheimer's disease treatment and care costs in European countries
Richard Cimler et al.
PLOS ONE (2019)
Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives
E. Riazimontazer et al.
BIOORGANIC CHEMISTRY (2019)
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
Killian Oukoloff et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
Tao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
Katarina Chalupova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease
Xiaoyu Zhang et al.
BIOORGANIC CHEMISTRY (2019)
A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer's Disease
Berenice Hatat et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease
Piyoosh Sharma et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
Bijo Mathew et al.
ARCHIV DER PHARMAZIE (2019)
Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions
Puja Mishra et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase
Bhupinder Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease
Ping Bai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multi-target design strategies for the improved treatment of Alzheimer's disease
Pengfei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease
Zhipei Sang et al.
ACS CHEMICAL NEUROSCIENCE (2019)
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Bhupinder Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
Ning Wang et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease
Avanish Tripathi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
Michael Grundman et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease
Anna Wieckowska et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents
Dawid Panek et al.
ACS CHEMICAL NEUROSCIENCE (2018)
In Silico Identification and Experimental Validation of Novel Anti-Alzheimer's Multitargeted Ligands from a Marine Source Featuring a 2-Aminoimidazole plus Aromatic Group Scaffold
Rosa Maria Vitale et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Alzheimer's Disease, the One-Molecule, One-Target Paradigm, and the Multitarget Directed Ligand Approach
Maria Jesus Oset-Gasque et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease
Xin Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment
Zhongcheng Cao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease
Xiao Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors
Moustafa T. Gabr et al.
BIOORGANIC CHEMISTRY (2018)
Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors
Bhupinder Kumar et al.
BIOORGANIC CHEMISTRY (2018)
Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents
Bhupinder Kumar et al.
CHEMMEDCHEM (2018)
Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease
Abida Batool et al.
CURRENT DRUG METABOLISM (2018)
] Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update
Matheus de Freitas Silva et al.
CURRENT MEDICINAL CHEMISTRY (2018)
A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease
Leili Jalili-Baleh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease
Asha Hiremathad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease
Yi-xiang Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mitochondria and Mitochondrial Cascades in Alzheimer's Disease
Russell H. Swerdlow
JOURNAL OF ALZHEIMERS DISEASE (2018)
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile
Oscar M. Bautista-Aguilera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl) Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents
Dawid Panek et al.
MOLECULES (2018)
Dual GSK-3 beta/AChE Inhibitors as a New Strategy for Multitargeting Anti -Alzheimer's Disease Drug Discovery
Xue-Yang Jiang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not
Shaoming Sang et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
Qi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Bhupinder Kumar et al.
CURRENT DRUG TARGETS (2017)
Synthesis of Novel Tacrine Analogs as Acetylcholinesterase Inhibitors
Mohammad Mahdavi et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2017)
A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease
Bilqees Sameem et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease
Jakub Jerabek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease
Shuang-shuang Yang et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Alzheimer's Disease: A Systemic Review of Substantial Therapeutie Targets and the Leading Multi-functional Molecules
Tarana Umar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Novel Vilazodone Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation
Xiaokang Li et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases
Oscar M. Bautista-Aguilera et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin
Jun Yan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Hybrid Compounds as Direct Multitarget Ligands: A Review
Michelle de Oliveira Pedrosa et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons
Sucharita Das et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondria energy metabolism
Jana Hroudova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation
Anna Wieckowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Nilotinib Effects in Parkinson's Disease and Dementia with Lewy Bodies
Fernando Pagan et al.
JOURNAL OF PARKINSONS DISEASE (2016)
One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
Rebecca E. Hughes et al.
FRONTIERS IN NEUROSCIENCE (2016)
Recent developments on the structure-activity relationship studies of MAO inhibitors and their role in different neurological disorders
Bhupinder Kumar et al.
RSC ADVANCES (2016)
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
Goran Simic et al.
BIOMOLECULES (2016)
Current and Future Treatments for Alzheimer Disease
Gary W. Small et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease
Fei Mao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model
Valentine Lahmy et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Are AD-typical regions the convergence point of multiple pathologies?
Sylvia Villeneuve et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study
Kosuke Matsuzono et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-beta Load and Cognitive Decline in Alzheimer's Disease
Markus Morawski et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Carvedilol Attenuates 6-Hydroxydopamine-Induced Cell Death in PC12 Cells: Involvement of Akt and Nrf2/ARE Pathways
Lan Wang et al.
NEUROCHEMICAL RESEARCH (2014)
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions
Sylvia Villeneuve et al.
NEUROLOGY (2014)
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cedric Lecoutey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
2013 Alzheimer's disease facts and figures Alzheimer's Association
William Thies et al.
ALZHEIMERS & DEMENTIA (2013)
A review on cholinesterase inhibitors for Alzheimer's disease
Preet Anand et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Matilde Yanez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
Blockade of Tau Hyperphosphorylation and Aβ1-42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease
Valentine Lahmy et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Associations Between Alzheimer Disease Biomarkers, Neurodegeneration, and Cognition in Cognitively Normal Older People
Miranka Wirth et al.
JAMA NEUROLOGY (2013)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Phosphodiesterases in neurodegenerative disorders
Eva Bollen et al.
IUBMB LIFE (2012)
From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease
Hailin Zheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Deferiprone Reduces Amyloid-β and Tau Phosphorylation Levels but not Reactive Oxygen Species Generation in Hippocampus of Rabbits Fed a Cholesterol-Enriched Diet
Jaya R. P. Prasanthi et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment
A. Minarini et al.
NEUROPHARMACOLOGY (2012)
Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases
Wei Zheng et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands
Cedric Lecoutey et al.
MEDCHEMCOMM (2012)
The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing
Hank F. Kung
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease
Qin Nie et al.
ACTA PHARMACOLOGICA SINICA (2011)
Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells
Feiqi Zhu et al.
BMC NEUROSCIENCE (2011)
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
Vanessa Villard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Carvedilol as a potential novel agent for the treatment of Alzheimer's disease
Jun Wang et al.
NEUROBIOLOGY OF AGING (2011)
Targeting HDACs: A Promising Therapy for Alzheimer's Disease
Ke Xu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2011)
Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
Veronica Berta Dorfman et al.
NEUROBIOLOGY OF AGING (2010)
Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease
Mark Kilgore et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Robert Vassar et al.
JOURNAL OF NEUROSCIENCE (2009)
Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice
Alexandra Bernardo et al.
NEUROBIOLOGY OF AGING (2009)
Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease Drugs
Orly Weinreb et al.
NEUROTHERAPEUTICS (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
D. Munoz-Torrero
CURRENT MEDICINAL CHEMISTRY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
Francisco Molina-Holgado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): A step forward in the treatment of Alzheimer's disease
Maria Laura Bolognesi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Hope in Alzheimer's fight emerges from unexpected places
Trisha Gura
NATURE MEDICINE (2008)
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease
Heng Du et al.
NATURE MEDICINE (2008)
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Rene O. Sanchez-Mejia et al.
NATURE NEUROSCIENCE (2008)
Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease
Magdolna Paskaski et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease
Yael Avramovich-Tirosh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors
Ana Castro et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Synthesis and pharmacology of galantamine
J Marco-Contelles et al.
CHEMICAL REVIEWS (2006)
Pathophysiology of Alzheimer's disease
BP Imbimbo et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2005)
Role of peroxisome proliferator-activated receptor γ in amyloid precursor protein processing and amyloid β-mediated cell death
C d'Abramo et al.
BIOCHEMICAL JOURNAL (2005)
Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease
M. Garcia-Alloza et al.
NEUROPSYCHOLOGIA (2005)
Monoamine oxidase-B inhibition in Alzheimer's disease
P Riederer et al.
NEUROTOXICOLOGY (2004)
Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide
IE Camacho et al.
JOURNAL OF NEUROSCIENCE (2004)
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain
A Caricasole et al.
JOURNAL OF NEUROSCIENCE (2004)
Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases
DR Brown et al.
DALTON TRANSACTIONS (2004)
Acetylcholinesterase inhibitors: novel activities of old molecules
M Racchi et al.
PHARMACOLOGICAL RESEARCH (2004)
Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization
S Pérez-Torres et al.
EXPERIMENTAL NEUROLOGY (2003)
Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease
BP Kennedy et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
β-Secretase (BACE) as a drug target for alzheimer's disease
R Vassar
ADVANCED DRUG DELIVERY REVIEWS (2002)
Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment -: Similarity with a virus fusion domain
O Crescenzi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease
H Kogen et al.
ORGANIC LETTERS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Role of GSK-3β in Alzheimer's disease pathology
E Planel et al.
DRUG DEVELOPMENT RESEARCH (2002)
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
A Martinez et al.
MEDICINAL RESEARCH REVIEWS (2002)
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
C Binda et al.
NATURE STRUCTURAL BIOLOGY (2002)
Acetylcholinesterase in Alzheimer's disease
VN Talesa
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Oxidative stress in Alzheimer's disease
MA Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
A novel three-component one-pot pyrimidine synthesis based upon a coupling-isomerization sequence
TJJ Muller et al.
ORGANIC LETTERS (2000)
Role of serotonin in memory impairment
HC Buhot et al.
ANNALS OF MEDICINE (2000)
Oxidative stress and Alzheimer disease
Y Christen
AMERICAN JOURNAL OF CLINICAL NUTRITION (2000)
Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors
H Sugimoto et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Share Paper
